cine levels in plasma of MSUD patients as well as loading experiments with R,S-2-0x0-3-methylpentanoate suggest a Lallo-iso-leucine pool with its own dynamics (8, 11, 12) .
Little is known about the regulation of L-isoleucine and L-alloisoleucine metabolism in human and animal tissues. In most studies on branched-chain amino and 2-0x0 acid metabolism, solely L-leucine and/or L-valine or the corresponding 2-0x0 acids were used as substrates. The aim of the present study was to demonstrate expected differences in the catabolism of the naturally occumng branched-chain amino acids including L-isoleucine and L-allo-isoleucine in human tissue. We therefore examined the transamination and oxidative decarboxylation rates in cultured skin fibroblasts of normal subjects and of a patient with variant MSUD using 14C-labeled branched-chain amino acids.
MATERIALS AND METHODS

Chemicals.
Unless otherwise noted, chemicals were purchased in the highest available purity from Merck, Darmstadt, or Sigma, Deisenhofen, FRG. Enzymes and coenzymes were from Boehringer, Mannheim, FRG, Acylase I (EC 3.5.1.14) was from Sigma, and Dowex 50 WX8, 50-100 mesh, was obtained from Serva, Heidelberg, FRG.
l-14C-labeled (leucine, 2.1 GBq/mmol; valine. 2.0 GBq/mmol) and U-'4C-labeled (leucine, 12.9 GBq/mmol; valine, 10.7 GBq/ mmol; isoleucine, 12.2 GBq/mmol) L-amino acids as well as NaHI4CO3 (2.1 GBq/mmol), KI4CN (370 MBq/mmol) and [methyl-14C]toluene standard were from New England Nuclear, Dreieich, FRG, or Amersham-Buchler, Braunschweig, FRG. Prior to use, unlabeled and radioactive amino acids were checked on a LC 6000 amino acid analyzer (Biotronik, Miinchen, FRG) in runs with and without ninhydrin, respectively. The purity was as specified by the suppliers.
I -14C-labeled L-isoleucine (8.6 MBq/mmol) and L-allo-isoleucine (13.3 MBq/mmol) were synthesized from KI4CN and the respective unlabelled amino acid essentially as described in (1 3). The products were characterized by coupled gaschromatographymass spectrometry of the trimethylsilyl-derivatives (c: $ 14). Purity (98%) was checked by amino acid analysis as described above and by treatment with D-amino acid oxidase (EC 1.4.3.3) according to ( 15) .
Cell culture. Human fibroblasts were obtained from skin biopsies of normal subjects (strain RE and WE, mixed at equal portions for assays) and of a patient with a variant form of maple syrup urine disease (intermittent type, strain JA). MSUD has been diagnosed in a 6-yr-old female, when she became ketoacidotic and lethargic triggered by a febrile illness. Cells were multiplied in monolayer culture in Eagle's minimum essential medium containing HEPES (20 mmol/liter), pH 7.2, 10% fetal calf serum, and penicillin and streptomycin. After 10-15 passages, fibroblasts at confluency were harvested by trypsinization,
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SCHADEWALDT AND WENDEL suspended in culture medium, washed twice with NaCl solution (0.154 mol/liter) by centrifugation and resuspended in phosphate buffered saline, Dulbecco's modification (PBS), with bovine serum albumin (1.5 g/liter) and D-glucose (12.4 mmol/liter). In general, cell concentration was adjusted to 1-2 x lo6 cells/ml and 0.4 ml of the suspension was used for one assay. Cell screening for mycoplasma contamination (16) was negative. Incubations. Fibroblasts (0.2-1 mg of cell protein) were incubated in a final volume of 0.9 ml at 37" C in a shaking water bath. I4CO2-tight incubation flasks were made from 22-ml glass scintillation vials essentially as described in (17) . The medium comprised PBS, D-glucose (5.5 mmol/liter), bovine serum albumin (0.07%) and ~-[~~C ] a m i n o acids as given in "Results." The reaction was started by addition of cell suspension and was terminated by injection of 0.3 ml HC1O4 (2 mmol/liter). Blanks were likely prepared, but cells were omitted. All samples were run in duplicate.
Assays. The I4CO2 release during incubation was completely absorbed in 0.5 ml ethanolamine-ethylenglycol (1:2, v:v) and measured by liquid scintillation counting (I 7). Thereafter, the 2-0x0-[I4C] acids in the medium were oxidatively decarboxylated by addition of.0.3 ml H202 solution (30%) as in (14) and the liberation of I4CO2 was determined with fresh trapping solution as described above. Stability of 2-0x0 acids and the oxidation procedure were examined with 2-0~0-4-methyl[l-~~C]pentanoate (prepared Estimation of total 2-0x0 acid content was a modification of the method described elsewhere (20) . At the end of the incubation, 0.8 ml of the assay mixture was withdrawn from the incubation flask, mixed with 0.1 ml standard solution (2-0x0-pentanoate, 33 pmol/liter; 2-oxohexanoate, 66 pmol/liter) and deproteinized with 0.5 ml HC1O4 (2 mol/liter). After centnfugation, 1 ml solution was mixed with 0.2 ml o-phenylendiamine (5 g/liter) in HCI (37%) and incubated for 60 min at 90" C. Then, pH 6 was adjusted by addition of 0.5 ml sodiumphosphate (0.5 mol/liter) and an appropriate volume of NaOH (8 moll liter) (2 1). After extraction with CHCI, (3 x 1 ml) and evaporation to dryness, the quinoxalinol derivatives were dissolved in 200 pl methanol and analyzed on a HPLC system (Merck, Darmstadt, FRG) using a Nucleosil 5CI8 column (250 X 4 mm, Macherey-Nagel, Diiren, FRG) equipped with a guard column (4 x 4 mm, Lichrosorb 100 RP-18, from Merck) and 27% CH3CN at 1.3 ml/min. F'luorimetric detection was as described previously (20) . Blanksand calibration standards(2-0x0-4-methylpentanoate and 2-0x0-methylbutanoate, 0-10 nmol/assay) with suspensions of unincubated fibroblasts were run in parallel.
Calculations. Metabolic rates were calculated from the appropriate I4CO2 liberation on the basis of the specific radioactivity ofthe C,-atom of the respective L-amin~['~C]acid in the medium. Transamination was calculated as the sum of I4CO2 production and 2-oxo[14C]acid release. Results are presented as means + SD of n independent experiments performed on different days. Statistically significant differences were determined by Student's paired t test.
RESULTS
Time and concentration dependence. Validity of methods was tested with normal fibroblasts. At 1 mmol/liter, the rate of I4CO2 and 2-0xo[l-~~C]acid release from all four I-I4C-labeled branched-chain L-amino acids remained essentially constant up to 120 min of incubation and subsequent incubations were camed out for 90 min. The metabolic activity of incubated fibroblasts (0.2-1 mg of cell protein/ml) was linearily correlated to cell mass (data not shown). Table  1 . In normal fibroblasts, I4CO2 production from leucine, valine, and isoleucine was similar (about 5 nmol/90 min/mg of cell protein). I4CO2 release from allo-isoleucine was distinctly lower and amounted to 28 + 4% of the value obtained with isoleucine.
Subst rate concentrat~on (mM1 ( 1 p < 0.05.
With each substrate, the release of the corresponding 2-oxo[14C]-acid was significantly higher than I4CO2 production.
The release of 2-0x0-4-methyl[14C]pentanoate was three times that of 2-0~0-3-methyl-['~C]butanoate and S-2-0x0-3-methyl-[I4C]pentanoate (from ile). R-2-0~0-3-methyl['~C]pentanoate
was released at 47 +-8% of the rate of its enantiomer.
Thus, leucine was transaminated at about twice the rate of valine and isoleucine, and the transamination of allo-isoleucine was about half of isoleucine (40 +. 5%). The portion of transamination products undergoing further degradation within the cells varied considerably from about one-half in incubations with valine to one-sixth in experiments with leucine.
In MSUD fibroblasts, transamination of branched-chain a m i n~[ '~C ] a c i d s neatly corresponded to the appropriate data obtained with normal cells, suggesting that branched-chain amino acid aminotransferase activity (EC 2.6.1.42) remained unchanged by the mutation. As anticipated however, I4CO2 production was lower. As compared to normal cells, the residual decarboxylation activity was differently reduced toward each substrate and amounted to 14, l I, 25, and 45% in incubations with leucine, valine, isoleucine, and allo-isoleucine, respectively. As related to the corresponding transamination rates, R-2-0x0-3-methylpentanoate was apparently the most suitable substrate for the mutant enzyme in this MSUD cell line.
In additional experiments with U-I4C-labeled L-leucine, Lvaline, and L-isoleucine with both normal and deficient fibroblasts, the release of I4C-labeled 2-0x0 acids was comparable to that observed with I-'4C-labeled substrates, whereas I4CO2 production was approx. twice as high (data not shown).
DISCUSSION
T o our knowledge, this the first study with intact human fibroblasts in which the transamination and the subsequent decarboxylation step in the catabolism of the four naturally occurring branched-chain amino acids, L-leucine, L-valine, Lisoleucine, as well as L-allo-isoleucine were investigated.
In our assay system, 2-0x0 acids formed by transamination of the respective branched-chain amino acids were estimated by chemical oxidation. By this method we found a considerably higher and far less variable 2-0x0 acid production from leucine and valine than Yoshida el al. (22) . In the latter study, 2-0x04-methylpentanoate and 2-0x0-3-methylbutanoate production was measured in a few experiments and differed by factors of about 5 and 10, respectively. As in numerous other studies (<I: Ref.
14), the chemical procedure proved reliable for 2-0x0 acid determination under the present assay conditions. 2-0x0 acid production as estimated by HPLC analysis of the quinoxalinol derivatives was somewhat higher. The reason for these differences, however, remained unclear. Likely, 2-0x0-3-methylbutanoate production from valine was somewhat underestimated, since in fibroblasts up to 10% of the 2-0x0-3-methylbutanoate might be converted to the respective 2-hydroxy acid which escapes our detection system. In contrast, hydroxy acid formation from 2-0x0-4-methylpentanoate and 2-0x0-3-methylpentanoate seems negligible. This has been shown with incubated fibroblasts (22) and further evidence is provided by a variety of clinical chemical findings (23) (24) (25) (26) (27) .
Decarboxylation of L-[l-14C]leucine and ~-[ l -'~C ] v a l i n e in skin fibroblasts has been examined by several investigators ( I , 22, 28), ~-[ I -~~] i s o l e u c i n e as a substrate has been used in only one study (I). Data for L-allo-isoleucine are not available. Under similar experimental conditions, in all studies, including the present one, I4CO2 measurements yielded surprisingly comparable decarboxylation rates (3-6 nmol/90 min/mg of cell protein). Furthermore, when the oxidative decarboxylation step was comparatively studied with branched-chain amino acids in intact cells, no preference of any substrate could be established ( 1, 22) . This is confirmed by the present results obtained with leucine, valine, and isoleucine.
With all substrates, transamination activity exceeded decarboxylation activity in fibroblasts ( 4 Ref. 22) . This is in accordance with all nonhepatic tissues so far studied including human muscle (1 7), and it is generally held that oxidative decarboxylation is the common rate-limiting step in branched-chain amino acid catabolism, except in the liver. In addition, apparently irrespective of the branched-chain amino acid concentration used or incubation time applied, a constant portion of the 2-0x0 acid formed within the cells did not get access to the mitochondria1 branched-chain 2-0x0 acid dehydrogenase complex. This was indicated by the constancy of the I4CO2 production to transamination ratio. The failure to detect significant differences in the oxidative decarboxylation rates and the distinct differences in transamination rates of individual branched-chain amino acids obtained with intact cells clearly contrast known properties of the (purified) enzymes involved. With branched-chain 2-0x0 acid dehydrogenase, which has been isolated from a variety of animal tissues, a differential activity against the substrates in the order of 2-0x0-3-methylbutanoate > S-2-0x0-3-methylpentanoate r 2-0x0-4-methylpentanoate > R,S-2-0x0-3-methylpentanoate has been observed (combined data from Refs. 29-32), whereas branched-chain amino acid aminotransferase has exhibited rather similar activities with the different branched-chain amino acids (33, 34) . Thus it appears that additional regulatory mechanisms, e.g. amino and/or 2-0x0 acid transport across cellular and intracellular membranes (35, 36) , may be engaged in the regulation of overall branched-chain amino acid metabolism in the intact cell.
As compared to isoleucine catabolism, the rate of transamination and of oxidative decarboxylation of L-[l-14C]allo-isoleucine catabolism were distinctly lower and amounted to 40 and 27%, respectively. Thus, the ratio of allo-isoleucine to isoleucine transamination in human fibroblasts was markedly lower than in rat tissue homogenates, the only data available for comparison (1 1). According to our findings, the significantly lower I4CO2 production from L-[l-14C]allo-isoleucine was due to the very low transamination rate and to the fact that only a minor portion (23%) of R-2-0x0-3-methylpentanoate was further oxidatively decarboxylated. The portion of S-2-0x0-3-methylpentanoate undergoing decarboxylation was significantly higher (34%). Whether the branched-chain 2-0x0 acid dehydrogenase complex degrades R-and S-2-0x0-3-methylpentanoate at different rates, however, is virtually unknown. Work is now in progress to elucidate this point in experiments with l-'4C-labeled 2-0x0 acids as substrates.
The degradation of the branched-chain amino acids was also studied in a cell line from a patient with variant MSUD. This strain with an only moderately reduced branched-chain 2-0x0 acid dehydrogenase complex activity was deliberately choosen in order to obtain reliable I4CO2 production. Branched-chain amino acid aminotransferase activity in these cells was apparently unchanged. As compared to controls, I4CO2 formation was significantly lower and more 2-0x0 acid accumulated. Moreover, the activity of the mutant branched-chain 2-0x0 acid dehydrogenase complex toward the four substrates was found to be apparently altered. Whereas I4CO2 production from l-'4C-labeled leucine and valine was reduced by about 90%, residual decarboxylation activity in experiments with isoleucine was 25% and with alloisoleucine even 45%. Decarboxylase activity of different MSUD cell lines with three branched-chain amino acids (leucine, valine, isoleucine) has been examined in one study. Regularly, the activity has been found to be concurrently reduced with all substrates (1). Thus, it remains to be investigated whether the present finding is a more general feature in variant MSUD or whether it is specific for the cell line under investigation.
